Reaction equation
C([N:14]1[CH2:17][C:16]([O:19][C:20]2[CH:25]=[C:24]([Br:26])[CH:23]=[CH:22][C:21]=2[O:27][CH2:28][C:29]2[CH:34]=[CH:33][CH:32]=[C:31]([Cl:35])[CH:30]=2)([CH3:18])[CH2:15]1)(C1C=CC=CC=1)C1C=CC=CC=1.ClCCOC=O>ClCCCl>[Br:26][C:24]1[CH:23]=[CH:22][C:21]([O:27][CH2:28][C:29]2[CH:34]=[CH:33][CH:32]=[C:31]([Cl:35])[CH:30]=2)=[C:20]([CH:25]=1)[O:19][C:16]1([CH3:18])[CH2:15][NH:14][CH2:17]1Participants
4
Conditions
- Temperature
- 90 °C
Procedure
The title compound from Step B (60 mg) was dissolved in DCE (10 mL) and chloroethylformate (0.2 mmol) was added. The mixture was heated at 80-100° C. for 1 h and concentrated. The residue was dissolved in MeOH (3 mL) and heated at 150° C. in a microwave reactor for another 1 h. The mixture was cooled to rt and purified via PTLC providing the title compound (30 mg). MS (ESI): mass calcd. for C17H17BrClNO2, 381.0; m/z found, 382.0 [M+H]+. 1H NMR (CDCl3): 7.43-7.23 (m, 4H), 7.12-7.06 (m, 1H), 6.86-6.78 (m, 2H), 5.12 (s, 2H), 4.24-4.16 (m, 2H), 3.78-3.67 (m, 2H), 1.67 (s, 3H).
Workup
- concentrationconcentrated
- dissolutionThe residue was dissolved in MeOH (3 mL)
- temperatureheated at 150° C. in a microwave reactor for another 1 h
- temperatureThe mixture was cooled to rt
- custompurified via PTLC
Sources & evidence
- ORD record
- ord-dd072f025a254296a3caa4036aa28404
- Source dataset
- uspto-grants-2014_02
- Patent number
- US08642583B2
Linked notes
Loading…